Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Total Non-Current Liabilities (2021 - 2025)

Historic Total Non-Current Liabilities for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $698.0 million.

  • Rxo's Total Non-Current Liabilities fell 529.17% to $698.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $698.0 million, marking a year-over-year decrease of 529.17%. This contributed to the annual value of $698.0 million for FY2025, which is 529.17% down from last year.
  • As of Q4 2025, Rxo's Total Non-Current Liabilities stood at $698.0 million, which was down 529.17% from $714.0 million recorded in Q3 2025.
  • Rxo's Total Non-Current Liabilities' 5-year high stood at $793.0 million during Q3 2024, with a 5-year trough of $182.0 million in Q4 2021.
  • For the 5-year period, Rxo's Total Non-Current Liabilities averaged around $597.7 million, with its median value being $624.0 million (2023).
  • As far as peak fluctuations go, Rxo's Total Non-Current Liabilities soared by 24120.88% in 2022, and later tumbled by 1159.42% in 2023.
  • Rxo's Total Non-Current Liabilities (Quarter) stood at $182.0 million in 2021, then soared by 241.21% to $621.0 million in 2022, then decreased by 11.59% to $549.0 million in 2023, then soared by 34.24% to $737.0 million in 2024, then decreased by 5.29% to $698.0 million in 2025.
  • Its Total Non-Current Liabilities stands at $698.0 million for Q4 2025, versus $714.0 million for Q3 2025 and $733.0 million for Q2 2025.